Vincent Key, MD
Orthopaedic Surgery · Kansas City, KSNPI 1235248279
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Titan Surgical Group, LLC accounts for 62.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $1,231 and has fallen 56.3% since, to $538 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in KS, where the typical reported total is $3,614.
Across 54 payments — averaging $75.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$3K
- Arthrex$618
- Smith+Nephew$413
- Ferring Pharmaceuticals Inc.$261
- Johnson & Johnson$68
- Amgen$62
- plus $117 from 6 others
What the payments were for
- Travel & lodging$52913%
- Food & beverage$1,17229%
- Education$2,40059%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 8 | $2,562 |
| Arthrex | 14 | $618 |
| Smith+Nephew | 6 | $413 |
| Ferring Pharmaceuticals Inc. | 15 | $261 |
| Johnson & Johnson | 2 | $68 |
| Amgen | 3 | $62 |
| Bioventus LLC | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Vertex | 1 | $20 |
| Avanos Medical | 1 | $20 |
| Linvatec Corporation | 1 | $19 |
| Nalu Medical, Inc. | 1 | $14 |
How this compares
$4,101 in reported general payments places this provider in the 50th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 177 | $555 |
| Celecoxib | 12 | $246 |
| Gabapentin | 12 | $205 |
| Clindamycin Hcl | 29 | $133 |
| Meloxicam | 16 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kansas City
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Brent WiseKansas City$97K
- John SchroeppelKansas City$28K
- Mitchell BirtKansas City$26K
- Spencer FalconKansas City$23K
- Bryan VopatKansas City$22K
- Katie SmeltzerKansas City$19K
- Everett WilkinsonKansas City$12K
- Jacob BrubacherKansas City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.